- £40.67m
- £79.18m
- £198.26m
- 33
- 88
- 52
- 61
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 6.05 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.41 | ||
| Price to Tang. Book | 2.08 | ||
| Price to Free Cashflow | 9.5 | ||
| Price to Sales | 0.21 | ||
| EV to EBITDA | 5.09 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.9% | ||
| Return on Equity | -4.56% | ||
| Operating Margin | 1.39% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 36.98 | 179.24 | 200.96 | 203.29 | 198.26 | 204.14 | 221.64 | 32.8% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +32.5 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
INSPECS Group plc is a United Kingdom-based provider of eyewear solutions for the global eyewear market. The Company produces a range of eyewear frames, low vision aids and lenses, covering optical, sunglasses and safety, which are either under license or under the Company’s own proprietary brands (Branded), or unbranded or private label on behalf of retail customers (OEM). The Company’s segments include Frames and Optics, which is involved in product distribution; Wholesale, which is engaged in OEM and manufacturing distribution, and Lenses which is engaged in manufacturing and distribution of lenses. The Company has operations in the United Kingdom, Germany, Portugal, Scandinavia, the United States and China (including Hong Kong, Macau and Shenzhen). Its customers are global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 75,000 points of sale.
Directors
- Ian Maclaurin NEC
- Robin Totterman CEO
- Christopher Kay CFO
- Angela Farrugia NID
- Christopher Hancock NID
- Richard Peck NID
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 25th, 2019
- Public Since
- February 27th, 2020
- No. of Employees
- 1,654
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
London Stock Exchange- Shares in Issue
- 101,671,525
- Address
- 7-10 Kelso Place, BATH
- Web
- https://inspecs.com/
- Phone
- Auditors
- Ernst & Young LLP
Latest News for SPEC
Upcoming Events for SPEC
Inspecs Group PLC Annual Shareholders Meeting
Inspecs Group PLC Annual Shareholders Meeting
Half Year 2025 Inspecs Group PLC Earnings Release
Similar to SPEC
Abingdon Health
London Stock Exchange
Advanced Medical Solutions
London Stock Exchange
Angle
London Stock Exchange
Aoti
London Stock Exchange
Aptamer
London Stock Exchange
FAQ
As of Today at 21:20 UTC, shares in Inspecs are trading at 40.00p. This share price information is delayed by 15 minutes.
Shares in Inspecs last closed at 40.00p and the price had moved by -27.93% over the past 365 days. In terms of relative price strength the Inspecs share price has underperformed the FTSE All Share Index by -29.91% over the past year.
The overall consensus recommendation for Inspecs is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreInspecs does not currently pay a dividend.
Inspecs does not currently pay a dividend.
Inspecs does not currently pay a dividend.
To buy shares in Inspecs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 40.00p, shares in Inspecs had a market capitalisation of £40.67m.
Here are the trading details for Inspecs:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: SPEC
Based on an overall assessment of its quality, value and momentum Inspecs is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Inspecs is 59.97p. That is 49.92% above the last closing price of 40.00p.
Analysts covering Inspecs currently have a consensus Earnings Per Share (EPS) forecast of £0.06 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Inspecs. Over the past six months, its share price has underperformed the FTSE All Share Index by -27.62%.
As of the last closing price of 40.00p, shares in Inspecs were trading -19.49% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Inspecs PE ratio based on its reported earnings over the past 12 months is 6.05. The shares last closed at 40.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Inspecs' management team is headed by:
- Ian Maclaurin - NEC
- Robin Totterman - CEO
- Christopher Kay - CFO
- Angela Farrugia - NID
- Christopher Hancock - NID
- Richard Peck - NID